Directed and managed business development / sales function for all sectors (civil, defense, commercial) in the technology areas of radioisotopes systems, nuclear thermal propulsion (NTP), and transportable fission power.Directs legislative affairs for civil and defense space.Oversees technology and product strategy for novel nuclear technologies in the space, defense, and transportable terrestrial markets.Responsible for IP strategy including patents, trademarks, and trade secrets.

Responsible for revenue generation and proposal management for "Space as a Service" deep space missions that provide payload hosting, comm relay, and proprietary data.

Built the company's business development function and advised the CEO on strategy for a first-of-its-kind deep space orbital payload hosting business model.

Responsible for the Instrument and Space Systems business line. This includes developing space resources technology roadmap and strategy for public / private partnerships with NASA & DoD.Responsible for IP strategy and commercialization.Deputy Program Manager for development of deep space exploration mission to near Earth asteroid.

Led a multidisciplinary engineering organization tasked with developing and manufacturing cutting-edge life science instrumentation.Responsible for Biosystems Engineering IP strategy.

Responsible for pairing market needs with technology solutions.Member of the Technology Assessment Board responsible for advising executive management on external technologies, companies, and industry developments.

Project Lead for medical / life science automation project developed under FDA and GMP/ISO regulations. Led development of an automated instrumentation product from invention through customer delivery and support. Oversaw a 20 person, multidisciplinary team in the development of an automation module, associated software, and consumables for an on-market instrument. Product opened up an out of reach defense market worth over $10M per year.Systems Lead for developing a portable, sample-to-answer diagnostic system under contract with Defense Threat Reduction Agency (DTRA). Assembled and directed a team of engineers and scientists in the development of a microsphere-based IVD instrument utilizing digital microfluidics to perform protein and nucleic acid assays for pathogen detection and host response. Efforts resulted in the DTRA awarding second phase to the program worth over $3M.Member of the Technology Assessment Board responsible for advising executive management on external technologies, companies, and industry developments.

Developed concept for, and successfully pitched a new product line to expand market share in the protein assay and bio-defense markets. Proposed a small-scale automation module to expand the usefulness of an on-market instruments allowing user to gain hours of productivity daily. The development and commercialization plan was accepted by executive management, received $4 million to develop product. Technical lead for integration of digital microfluidic technology in a medical diagnostic systemTechnical lead for DARPA research grant to study universal sample preparation.Designed electronics architecture for a bead-based, multiplexed imaging instrument. Responsible for electronics containing robotics, fluidics, CCD imaging, and image processing. This instrument has become the platform on which all future bead-based systems will be modeled.

Principle investigator for bio-defense contract, "xChip", completed ahead of schedule and under budget. Received “Top Inventor 2007” award for having the most significant patent filing for the Luminex in 2007. Patent covers an automation instrument that was developed into a product making the company competitive in the bio-defense market.

Member of the team that developed new strategic vendor relationship for PCBAs.Designed power management PCBA and avalanche photodiode array PCBA for FLEXMAP 3D.Improved signal to noise in the LX200 analog signal processing.Existing flow cytometry instrumentation is fragile, time consuming to produce, and requires substantial maintenance. Proposed a chip-scale miniaturization of the core optics, fluidics, and electronics. Secured a 1 year, $300,000 grant from the DARPA to complete a Phase 1 feasibility evaluation. Led team to reduce fluid consumption of a flow cytometer by 10x without loss in optical performance and maintained existing throughput.

Responsible for design and construction of high voltage diagnostic equipment.Performed microwave excited, plasma experiments.

Assisted in design, construction, and testing of high energy pulsed power devices. Designed, assembled, and tested high power solid-state power converters.